1. Home
  2. INSE vs CRDL Comparison

INSE vs CRDL Comparison

Compare INSE & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

HOLD

Current Price

$6.99

Market Cap

189.7M

Sector

Technology

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.33

Market Cap

154.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSE
CRDL
Founded
2002
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
154.1M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
INSE
CRDL
Price
$6.99
$1.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$14.00
$8.50
AVG Volume (30 Days)
87.4K
693.8K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$199,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.25
N/A
52 Week Low
$6.11
$0.88
52 Week High
$9.95
$1.71

Technical Indicators

Market Signals
Indicator
INSE
CRDL
Relative Strength Index (RSI) 49.34 49.53
Support Level $6.70 $0.95
Resistance Level $7.64 $1.43
Average True Range (ATR) 0.32 0.11
MACD 0.04 -0.03
Stochastic Oscillator 43.52 12.79

Price Performance

Historical Comparison
INSE
CRDL

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: